Journal
JAMA Network Open
Publication Date
4-1-2022
Volume
5
Issue
4
First Page
e226269
Document Type
Open Access Publication
DOI
10.1001/jamanetworkopen.2022.6269
Rights and Permissions
Lee TC, Vigod S, Bortolussi-Courval É, et al. Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(4):e226269. doi:10.1001/jamanetworkopen.2022.6269. This is an open access article distributed under the terms of the CC-BY License.
Recommended Citation
Lee, Todd C; Vigod, Simone; Bortolussi-Courval, Émilie; Hanula, Ryan; Boulware, David R; Lenze, Eric J; Reiersen, Angela M; and McDonald, Emily G, "Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: A systematic review and meta-analysis." JAMA Network Open. 5, 4. e226269 (2022).
https://digitalcommons.wustl.edu/oa_4/565
eMethods. Statistical Code eTable 1. Details of Randomized Controlled Trials Identified in Search of Registry eFigure 1. Forest Plot of Bayesian Analysis With Weakly Neutral Prior eFigure 2. Forest Plot of Bayesian Analysis With Moderately Optimistic Prior eTable 2. Considerations for Relative Contraindications to Fluvoxamine
